Canada Pension Plan Investment Board Travere Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$7.64 - $17.25 $1.71 Million - $3.86 Million	224,000 New	224,000 $2 Million
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $15.3 Million - $21.9 Million	-731,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $5.19 Million - $6.73 Million	220,000 Added 43.05%	731,000 $18.8 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $1.29 Million - $1.65 Million	53,000 Added 11.57%	511,000 $15.9 Million
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $1.3 Million - $2.5 Million	100,000 Added 27.93%	458,000 $11.1 Million
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $5.05 Million - $9.45 Million	358,000 New	358,000 $5.22 Million

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.